Point of Care Testing to Improve Monitoring of LVAD Patients

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2023

Primary Completion Date

July 30, 2024

Study Completion Date

August 30, 2024

Conditions
Anticoagulation and Thrombosis Point of Care Test (AT-POCT)
Interventions
DEVICE

Anticoagulation and Thrombosis Point of Care Test(AT-POCT)

Capillary action automatically draws blood into the channel containing printed assay reagents which solubilize upon contact with blood and react with analytes of interest.

DEVICE

Duke Central Automated Laboratory (DCAL)

DCAL measurement of INR will occur by an ACL TOP 750 Analyzer (IL Inc.), and LDH by standard enzymatic activity assay will be run on the automated Beckman DxC800.

Trial Locations (1)

27705

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT03555552 - Point of Care Testing to Improve Monitoring of LVAD Patients | Biotech Hunter | Biotech Hunter